The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
18 Month Outcomes from Multicenter RCT: Spinal Cord Stimulation at 10kHz for Non-Surgical Refractory Back Pain
$0$0.00
Standard Price
This product is also available as part of the following products:
* Precision Medicine: The Next Great Medical Horizon
Synopsis
Spinal cord stimulation (SCS) is primarily used to treat persistent back and leg pain following spine surgery, but minimal evidence existed to show efficacy in patients who were surgery naïve. This randomized controlled trial was designed to demonstrate the clinical efficacy of 10kHz SCS in chronic back pain patients who were surgery naïve and not acceptable candidates for surgery. Recently published 12-month results showed profound improvements in pain relief, function, and quality of life with 10kHz SCS over conventional medical management for non-surgical refractory back pain (NSRBP) patients. We now report 18-month results demonstrating the durability of these therapeutic outcomes.
Disclosures
Taissa Cherry, MD has contracted research with Nevro Corp, with all funds going to her institution
Jessica Jameson, MD receives consulting and speaking fees from Nevro, Boston Scientific
Naresh P. Patel, MD has contracted research with Nevro Corp, with all funds going to his institution
Curtis Johnson, MD has contracted research with Nevro Corp
Daniel Kloster, MD has contracted research with Nevro Corp
Aaron K. Calodney, MD AC receives consulting fees from Nevro Corp.
Rose Province-Azalde, MS Employee of Nevro Corp.
Leonardo Kapural, MD, PhD on scientific advisory board for Abbott, Nevro, Saluda, SPR therapeutics, Neuros, Halyard. Is a consultant: Gimer Medical, Best Doctors, Solis Medical, Nalu Medical, Biotronik, Nevro, and has research contracts with Stimwave, Nevro, Neuros, Halyard, SPR therapeutics, Boston Scientific, Medtronic, Saluda.
Here we propose a characterization of Fibromyalgia pathophysiology in gray matter (GM) tissue using a multimodal neuroimaging approach (volumetric, diffusion-weighted, and resting-state functional connectivity)…
In order to overcome barriers to adoption of neurostimulation technologies by patients and clinicians, we present here a minimally invasive needle placeable and fully implanted neurostimulator that is suitable for clinical imaging (U/S, X-Ray, MRI)…
Post dural puncture headaches are, more recently, being documented as a complication related to spinal cord stimulator placement. Dural compromise are usually appreciated prior to this condition's onset. A viable treatment for post dural headaches is epidural blood patches…